Drugmakers’ push boosts ‘murky’ ailment

Two drugmakers spent hundreds of millions of dollars last year to raise awareness of a murky illness, helping boost sales of pills recently approved as treatments and drowning out unresolved questions _ including whether it’s a real disease at all. Key components of the industry-funded buzz over the pain-and-fatigue ailment fibromyalgia are grants _ more than $6 million donated by drugmakers Eli Lilly and Pfizer in the first three quarters of 2008 _ to nonprofit groups for medical conferences and educational campaigns, an Associated Press analysis found. Image source: washingtonpost.com. > Continue.

News selected by Covalence | Country: USA | Company: Eli Lilly, Pfizer | Source: Associated Press